Rodent models of experimental autoimmune uveitis.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Methods in Molecular Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1385/1-59259-805-6:395PMID 15286397
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hydrodynamic delivery of DNA.

  2004cited by this paper
• Dissociating the Enhancing and Inhibitory Effects of Pertussis Toxin on Autoimmune Disease

  2003cited by this paper
• A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice.

  2003cited by this paper
• Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity.

  2002cited by this paper
• GENETIC CONTROL OF SUSCEPTIBILITY IN CLINICAL AND EXPERIMENTAL UVEITIS

  2002cited by this paper
• Identification of Bphs, an Autoimmune Disease Locus, as Histamine Receptor H1

  2002cited by this paper
• Spontaneous retinopathy in HLA-A29 transgenic mice

  2001cited by this paper
• Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice.

  2001cited by this paper
• Pertussis Toxin Inhibits Induction of Tissue-Specific Autoimmune Disease by Disrupting G Protein-Coupled Signals

  2001cited by this paper
• CD4 and CD8 Expression by Dendritic Cell Subtypes in Mouse Thymus and Spleen1

  2000cited by this paper
• Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.

  2000cited by this paper
• Analysis of experimental autoimmune encephalomyelitis induced in F344 rats by pertussis toxin administration.

  2000cited by this paper
• The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.

  1999cited by this paper
• Pregnancy ameliorates induction and expression of experimental autoimmune uveitis.

  1999cited by this paper
• IL-10 has a protective role in experimental autoimmune uveoretinitis.

  1998cited by this paper
• Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H‐2Ak‐carrying mice

  1998cited by this paper
• Thymic expression of autoantigens correlates with resistance to autoimmune disease.

  1997cited by this paper
• Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response.

  1997cited by this paper
• Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response.

  1996cited by this paper
• Alternative routes of immunization for the induction of experimental autoimmune uveoretinitis (EAU) in rodents: a comparison.

  1995cited by this paper
• Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype.

  1995cited by this paper
• Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice.

  1994cited by this paper
• Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat.

  1993cited by this paper
• Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6.

  1993cited by this paper
• Control of experimental autoimmune uveoretinitis by low dose T cell vaccination.

  1992cited by this paper
• Genetic factors in susceptibility and resistance to experimental autoimmune uveoretinitis.

  1992cited by this paper
• Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes.

  1992cited by this paper
• Immunogenetic aspects of clinical and experimental uveitis.

  1992cited by this paper
• Analysis of the pivotal residues of the immunodominant and highly uveitogenic determinant of interphotoreceptor retinoid-binding protein.

  1991cited by this paper
• Unusual immunologic properties of the uveitogenic interphotoreceptor retinoid-binding protein-derived peptide R23.

  1991cited by this paper
• Regulation of experimental autoimmune uveitis in rats—separation of MHC and non‐MHC gene effects

  1991cited by this paper
• Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes.

  1991cited by this paper
• Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats.

  1990cited by this paper
• Pathology of experimental autoimmune uveoretinitis in mice.

  1990cited by this paper
• Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis.

  1989cited by this paper
• Basic Mechanisms in Immune-mediated Uveitic Disease

  1989cited by this paper
• Interphotoreceptor retinoid-binding protein. Gene characterization, protein repeat structure, and its evolution.

  1989cited by this paper
• Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP)

  1989cited by this paper
• Synthetic peptides derived from IRBP induce EAU and EAP in Lewis rats.

  1988cited by this paper
• A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.

  1988cited by this paper
• Rhodopsin-induced experimental autoimmune uveoretinitis: dose-dependent clinicopathological features.

  1988cited by this paper
• Human S-antigen: characterization of uveitopathogenic sites.

  1988cited by this paper
• Identification of a uveitopathogenic and lymphocyte proliferation site in bovine S-antigen.

  1988cited by this paper
• S-antigen: characterization of a pathogenic epitope which mediates experimental autoimmune uveitis and pinealitis in Lewis rats.

  1987cited by this paper
• Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein.

  1986cited by this paper
• Chapter 3 Retinal specific antigens and immunopathogenic processes they provoke

  1986cited by this paper
• T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat.

  1986cited by this paper
• Molecular biology of the visual pigments.

  1986cited by this paper
• Retinal S-antigen epitopes in vertebrate and invertebrate photoreceptors.

  1985cited by this paper
• Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features.

  1985cited by this paper
• Retinal S antigen identified as the 48K protein regulating light-dependent phosphodiesterase in rods.

  1985cited by this paper
• An association between susceptibility to experimental autoimmune uveitis and choroidal mast cell numbers.

  1984cited by this paper
• S antigen-induced experimental autoimmune uveo-retinitis in rats.

  1981cited by this paper
• Autoimmunity and the retina.

  1980cited by this paper
• Autoimmune uveo-retinitis in the rat sensitized with retina photoreceptor cell antigen.

  1973cited by this paper
• Homoimmune Uveitis in the Guinea Pig: II. Clinical Manifestations

  1963cited by this paper
• Homoimmune Uveitis in the Guinea Pig: I. General Concepts of Auto- and Homoimmunity, Methods, and Manifestations

  1963cited by this paper
• Homoimmune Uveitis in the Guinea Pig: III. Histopathologic Manifestations of the Disease

  1963cited by this paper
• Serial Adoptive Transfer of Experimental Autoimmune Uveoretinitis In Rats

  year unknowncited by this paper

• Macrophage immunosenescence prolongs intraocular inflammation in aged mice via impaired induction of regulatory T cells

  2026cites this paper
• Artesunate ameliorates experimental autoimmune uveitis by inhibiting the LCN2-STAT3 axis and suppressing microglial activation

  2026cites this paper
• Gut microbial alterations associated with the exacerbation of experimental autoimmune uveitis in PGRN-deficient mice

  2026cites this paper
• Restoration of Immune Homeostasis: The Role of miR-30b-5p and Notch Signaling in Uveitis After Treatment With Longdan Xiegan Decoction

  2025cites this paper
• Inhibition of bruton’s tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis

  2025cites this paper
• Lipid metabolism analysis reveals that DGAT1 regulates Th17 survival by controlling lipid peroxidation in uveitis

  2025cites this paper
• Muscone Attenuates Uveitis Through the PI3K/AKT Signaling Pathway

  2025cites this paper
• The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitis

  2025cites this paper
• Chronic sleep deprivation promotes experimental autoimmune uveitis through STAT1 phosphorylation, ISG15 expression and enhanced pathogenicity of macrophages.

  2025cites this paper
• Vitamin A is necessary for acquisition, but not for expression or progression, of CNS autoimmunity

  2025cites this paper
• Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope–Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice

  2025cites this paper
• Upregulation of lipocalin-2 in the retina of experimental autoimmune uveitis

  2025cites this paper
• Therapeutic effect of miR-30b-5p-loaded lentivirus on experimental autoimmune uveitis via inhibiting Notch signaling activation

  2025cites this paper
• Laminated Layer Extract from Echinococcus Granulosus cyst Attenuates Ocular Damages and Inflammatory Responses in an Experimental Autoimmune Uveitis Model

  2025cites this paper
• Neutrophil extracellular traps potentiate effector T cells via endothelial senescence in uveitis

  2025cites this paper
• Kinetic changes in microglia-related retinal transcripts in experimental autoimmune uveoretinitis (EAU) of B10.RIII mice

  2025cites this paper
• The Therapeutic Effects of Purified Cortrophin Gel on Experimental Autoimmune Uveitis

  2025cites this paper
• The Role of Retinal Antigen-Presenting Cells in Spontaneous Retinal Autoimmunity

  2025cites this paper
• Baicalin prevents experimental autoimmune uveitis by promoting macrophage polarization balance through inhibiting the HIF-1α signaling pathway

  2025cites this paper
• Comparative models of uveitis

  2025cites this paper
• Laquinimod treatment attenuates EAU by inhibiting both the inductive and effector phases in an APC-dependent manner

  2025cites this paper
• Single-cell RNA sequencing reveals beneficial mechanisms of Exendin-4 in autoimmune uveitis.

  2025cites this paper
• Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis

  2024cites this paper
• Itaconate Ameliorates Experimental Autoimmune Uveitis by Modulating Teff/Treg Cell Imbalance Via the DNAJA1/CDC45 Axis

  2024cites this paper
• Transcription factor EGR2 alleviates autoimmune uveitis via activation of GDF15 to modulate the retinal microglial phenotype

  2024influential citation
• Oral Administration of Piperine Ameliorates Experimental Autoimmune Uveitis

  2024cites this paper
• Effect of intravitreal injection of anti-interleukin (IL)-6 antibody in experimental autoimmune uveitis in mice

  2024cites this paper
• CCR5-overexpressing mesenchymal stem cells protect against experimental autoimmune uveitis: insights from single-cell transcriptome analysis

  2024influential citation
• Beneficial mechanisms of dimethyl fumarate in autoimmune uveitis: insights from single-cell RNA sequencing

  2024influential citation
• RBPJ Knockdown Promotes M2 Macrophage Polarization Through Mitochondrial ROS-mediated Notch1-Jagged1-Hes1 Signaling Pathway in Uveitis

  2024cites this paper
• Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis

  2024cites this paper
• Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet’s uveitis

  2024cites this paper
• Single‐cell RNA sequencing reveals inflammatory retinal microglia in experimental autoimmune uveitis

  2024cites this paper
• Crystallin β-b2 promotes retinal ganglion cell protection in experimental autoimmune uveoretinitis

  2024cites this paper
• Dimethyl itaconate inhibits antigen‐specific Th17 cell responses and autoimmune inflammation via modulating NRF2/STAT3 signaling

  2024cites this paper
• The Complement System as a Therapeutic Target in Retinal Disease

  2024cites this paper
• Therapeutic Effects of Upadacitinib on Experimental Autoimmune Uveitis: Insights From Single-Cell Analysis

  2023cites this paper
• Identification of Hif1α as a Potential Participant in Autoimmune Uveitis Pathogenesis Using Single-Cell Transcriptome Analysis

  2023cites this paper
• Growth hormone releasing hormone signaling promotes Th17 cell differentiation and autoimmune inflammation

  2023cites this paper
• A diet rich in fermentable fiber promotes robust changes in the intestinal microbiota, mitigates intestinal permeability, and attenuates autoimmune uveitis

  2023cites this paper
• Single-cell analysis of immune cells on gingiva-derived mesenchymal stem cells in experimental autoimmune uveitis

  2023cites this paper
• A machine learning framework for the quantification of experimental uveitis in murine OCT

  2023cites this paper
• IL-8 Triggers Neutrophil Extracellular Trap Formation Through an Nicotinamide Adenine Dinucleotide Phosphate Oxidase- and Mitogen-Activated Protein Kinase Pathway-Dependent Mechanism in Uveitis

  2023cites this paper
• METTL3 inhibits autoreactive Th17 cell responses in experimental autoimmune uveitis via stabilizing ASH1L mRNA

  2023cites this paper
• Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis

  2023cites this paper
• A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing

  2023cites this paper
• Local Myeloid-Derived Suppressor Cells Impair Progression of Experimental Autoimmune Uveitis by Alleviating Oxidative Stress and Inflammation

  2023cites this paper
• Prednisone acetate modulates Th1/Th2 and Th17/Treg cell homeostasis in experimental autoimmune uveitis via orchestrating the Notch signaling pathway.

  2023cites this paper
• Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization

  2023cites this paper
• Effect of small extracellular vesicles derived from IL-10-overexpressing mesenchymal stem cells on experimental autoimmune uveitis

  2022cites this paper
• Apolipoprotein A1 Modulates Teff/Treg Balance Through Scavenger Receptor Class B Type I-Dependent Mechanisms in Experimental Autoimmune Uveitis

  2022cites this paper
• Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model.

  2022cites this paper
• Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy

  2022cites this paper
• Blood-retina barrier dysfunction in experimental autoimmune uveitis: the pathogenesis and therapeutic targets

  2022cites this paper
• Antimetabolite Drugs Exhibit Distinctive Immunomodulatory Mechanisms and Effects on the Intestinal Microbiota in Experimental Autoimmune Uveitis

  2022cites this paper
• Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease

  2022cites this paper
• Vitamin A, systemic T-cells, and the eye: Focus on degenerative retinal disease

  2022influential citation
• Melatonin, an endogenous hormone, modulates Th17 cells via the reactive-oxygen species/TXNIP/HIF-1α axis to alleviate autoimmune uveitis

  2022cites this paper
• MYC-mediated silencing of miR-181a-5p promotes pathogenic Th17 responses by modulating AKT3-FOXO3 signaling

  2022influential citation
• NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2‐Mediated Pyroptosis Through the Phosphorylated Salt‐Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway

  2022cites this paper
• Multimodal evaluation of an interphotoreceptor retinoid-binding protein-induced mouse model of experimental autoimmune uveitis

  2022cites this paper
• Succinic acid exacerbates experimental autoimmune uveitis by stimulating neutrophil extracellular traps formation via SUCNR1 receptor

  2022cites this paper
• Pathogenesis and current therapies for non-infectious uveitis

  2022cites this paper
• Parabiosis reveals the correlation between the recruitment of circulating antigen presenting cells to the retina and the induction of spontaneous autoimmune uveoretinitis

  2022influential citation
• Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye

  2022cites this paper
• Genetic Ablation of Nrf2 Exacerbates Neuroinflammation in Ocular Autoimmunity

  2022cites this paper
• The Topical Ocular Delivery of Rapamycin to Posterior Eye Tissues and the Suppression of Retinal Inflammatory Disease.

  2022cites this paper
• Long-acting acid-sensitive ketal-linked dexamethasone microcrystals for treating experimental autoimmune uveitis

  2022cites this paper
• Mesenchymal stromal cells for the treatment of ocular autoimmune diseases.

  2021cites this paper
• Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis

  2021cites this paper
• Construction of animal models of uveitis with traditional Chinese medicine syndrome: a narrative review

  2021cites this paper
• Longdan Xiegan Decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation.

  2021cites this paper
• Immune-Mediated Retinal Vasculitis in Posterior Uveitis and Experimental Models: The Leukotriene (LT)B4-VEGF Axis

  2021cites this paper
• CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation

  2021cites this paper
• Blocking the inflammasome: a novel approach to treat uveitis.

  2021cites this paper
• Quantitative Assessment of Experimental Ocular Inflammatory Disease

  2021cites this paper
• Aging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice

  2021cites this paper
• Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity

  2021cites this paper
• MiR-379-5p aggravates experimental autoimmune uveitis in mice via the regulation of SEMA3A

  2021cites this paper
• Beneficial effect of dimethyl fumarate on experimental autoimmune uveitis is dependent of pro-inflammatory markers immunomodulation

  2021cites this paper
• Uveitis‐mediated immune cell invasion through the extracellular matrix of the lens capsule

  2021cites this paper
• Bene cial Effect of Dimethyl Fumarate on Experimental Autoimmune Uveitis is Dependent of Pro-In ammatory Markers Immunomodulation

  2021cites this paper
• Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis

  2021cites this paper
• Characterization of a Novel Caveolin Modulator That Reduces Vascular Permeability and Ocular Inflammation

  2021cites this paper
• CD4+ T-Cell Plasticity in Non-Infectious Retinal Inflammatory Disease

  2021cites this paper
• Vaccination with circulating exosomes in autoimmune uveitis prevents recurrent intraocular inflammation

  2021cites this paper
• Identifying Mouse Autoimmune Uveitis from Fundus Photographs Using Deep Learning

  2020cites this paper
• The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24

  2020cites this paper
• IFNA1 and IFNA13 Genes Confer Genetic Predisposition to Ankylosing Spondylitis-Associated Uveitis in a Chinese Population

  2020cites this paper
• Single-Domain Antibodies: Biology, Engineering and Emerging Applications

  2020cites this paper
• NATURAL PRODUCTTS AND MEDICINAL PLANTS: BOOSTING IMMUNE SYSTEM AGAINST COVID-19 AND OTHER VIRUSES

  2020cites this paper
• Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis

  2019cites this paper
• Disruption of Intestinal Homeostasis and Intestinal Microbiota During Experimental Autoimmune Uveitis

  2019cites this paper
• The role of immune regulatory cells in sight-threatening non-infectious uveitis

  2019cites this paper
• Retinal microglia initiate neuroinflammation in ocular autoimmunity

  2019cites this paper
• Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand

  2019influential citation
• AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis

  2019cites this paper
• Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis

  2019cites this paper
• Zinc Nutrition and Inflammation in the Aging Retina.

  2019cites this paper
• IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases

  2019cites this paper